Asahi Kasei's Functional Additives Division produces and commercializes Ceolus™ microcrystalline cellulose (MCC) drug tablet excipients, and HA (Hyaluronic Acid) nanogel - base material for injection formulations.
Improving the quality of life for people around the world is one of Asahi Kasei’s primary focal points driving its innovation, and Asahi Kasei remains committed to meeting the needs of customers through products that contribute to life and living for people around the world.